287840.KQ IntoCell, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
02:15
Feb 10
Feb 10
Stable linker technology enables safer ADC
IntoCell owns ADC linker technology that keeps the payload stably attached in the bloodstream and releases it only inside cancer cells, addressing the risk of premature payload release that can damage normal tissue. The company is building references with major partners such as Samsung Bioepis, has insider buying, and is starting multiple clinical trials this year, giving it broad partnering potential across ADC payloads.
MED
About 287840.KQ Investor Commentary
Across the available history and selected sources, Buzzberg tracks 287840.KQ (IntoCell, Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Noh Young-rae.